Decheng Capital Global Life Sciences Fund IV, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for CG ONCOLOGY, INC. Common stock, $0.0001 par value per share (CGON)

Filing Manager
Decheng Capital Global Life Sciences Fund IV, L.P.
Reporting Manager
Xiangmin Cui
Security
CG ONCOLOGY, INC. Common stock, $0.0001 par value per share
Symbol
CGON
Shares outstanding
75,853,202 shares
Disclosed Ownership
6,371,669 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:40:02 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Decheng Capital Global Life Sciences Fund IV, L.P. 7% 5,315,954 0 5,315,954 /s/ Xiangmin Cui By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Decheng Capital Management IV (Cayman), LLC 7% 5,315,954 0 5,315,954 /s/ Xiangmin Cui By Xiangmin Cui, Manager
Decheng Capital Global Healthcare Fund (Master), LP 1.4% 1,055,715 0 1,055,715 /s/ Xiangmin Cui By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Decheng Capital Global Healthcare GP, LLC 1.4% 1,055,715 0 1,055,715 /s/ Xiangmin Cui By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Xiangmin Cui 8.4% 6,371,669 0 6,371,669 /s/ Xiangmin Cui Xiangmin Cui